Lyell Immunopharma Q1 2026 Earnings Narrower Loss Surprises Expectations Amid Clinical Progress ORKA Q1 2026 Earnings NarrowerThanExpected Loss Highlights Cost Discipline IMO Q1 2026 Earnings EPS Misses Estimates as Earnings Decline 1955 Below Consensus Galectin Therapeutics Q1 2026 Earnings EPS Misses Estimates Stock Rallies on Operational Progress TaskUs Inc TASK Q1 2026 Earnings Small EPS Miss on Modest Revenue Uncertainty KNOT Offshore Partners Q4 2025 Earnings Significant EPS Miss Amid Challenging Market Conditions